Alniditan (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code name R-91274) is a selective serotonin 5-HT1B and 5-HT1D receptor agonist with migraine-preventive effects which was never marketed. It was under development for treatment of migraine via subcutaneous injection in the 1990s and reached phase 3 clinical trials for this indication prior to the discontinuation of its development.
Alniditan (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code name R-91274) is a selective serotonin 5-HT1B and 5-HT1D receptor agonist with migraine-preventive effects which was never marketed. It was under development for treatment of migraine via subcutaneous injection in the 1990s and reached phase 3 clinical trials for this indication prior to the discontinuation of its development.
Source: Wikipedia "Alniditan" · CC BY-SA 4.0
Share this article: X · Bluesky